Is preoperative psoas muscle size and/or postoperative vasopressor-intrope drug dosages associated with outcomes after heart and/or lung transplantation

Psoas Muscle Size and Postoperative Vasopressor-Inotrope Score as a predictor of outcomes in heart and/or lung transplant patients

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12620001218987

Enrollment

200

Registered

2020-11-16

Start date

2021-02-01

Completion date

Unknown

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A retrospective cohort study will review patient records to calculate a vasoactive-inotropic score for patients who have undergone heart and/or lung transplantation. Additionally in those patients who have has an abdominal CT scan in the preoperative period a psoas muscle cross sectional area (PMCSA) will be calculated. The objective is to assess the association between the VIS and the PMCSA and whether either measure is associated with post-operative outcomes.

Interventions

Retrospective observational cohort study using patient medical records to investigate whether preoperative psoas muscle size measured on CT scans and/or the vasopressor-intotrope score predict postoperative outcomes after heart and/or lung transplantation. Records from patients transplanted at St Vincent’s Hospital, Sydney from 1st January 2016 to 30th September 2020 will be accessed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Heart and/or Lung Transplantation

Exclusion criteria

None

Outcome results